RETAL publishes its seventh annual Sustainability Report this week, highlighting clear progress in embedding sustainability across its global operations.

Latest Sustainability Report shows RETAL continues to lead in sector


Key achievements in 2024 include setting more ambitious GHG reduction targets, clear progress towards these targets, expanding the use of renewable electricity with seven out of ten plants operating at 100 percent, increasing recycled content with 58,000 tonnes of recycled PET processed, improving our Social and Governance action and reinforcing accountability by joining the UN Global Compact, alongside maintaining strong third-party ratings.

Emmanuel Duffaut, RETAL Chief Sustainability Officer, says, “This report highlights just how far RETAL has come since I joined in 2018; it’s proof of the consistent dedication from our top management in embedding sustainability as a strategic priority. In 2024, we took further steps to address major environmental impacts, while never losing sight of our holistic sustainability management promise by fully addressing all the topics that are material to RETAL.”

As an industry leader in sustainable plastic packaging, RETAL continues to demonstrate ongoing, provable results that strengthen its role as a trusted partner for global food and beverage brands.

To read and download the 2024 Sustainability Report, please visit retalgroup.com/csr

More Info(RETAL)

Keywords

sustainability , retal , report , global

Rate this article

Follow us on LinkedIn

Share this article

Comments (0)

Leave a comment...

Related Articles

Are you a packaging enthusiast?

If you'd like to be showcased in our publication at no cost, kindly share your story, await our editor's review, and have your message broadcasted globally.

packaging

sustainability

retal

sustainable

global

plastic

article

report

pharma

about

packaging

sustainability

retal

sustainable

global

plastic

article

report

pharma

about

packaging

sustainability

retal

sustainable

global

plastic

article

report

pharma

about